Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

Y. Maehara; I. Takahashi; M. Yoshida; H. Baba; H. Kusumoto; H. Anai; K. Sugimachi

Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

Y. Maehara, I. Takahashi, M. Yoshida, H. Baba, H. Kusumoto, H. Anai, K. Sugimachi

Surgery

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

Original language	English
Pages (from-to)	27-29
Number of pages	3
Journal	Anticancer research
Volume	13
Issue number	1
Publication status	Published - 1993

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{4bf5807cd4e34e7f844d2c7a55f99927,

title = "Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65",

abstract = "We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.",

author = "Y. Maehara and I. Takahashi and M. Yoshida and H. Baba and H. Kusumoto and H. Anai and K. Sugimachi",

year = "1993",

language = "English",

volume = "13",

pages = "27--29",

journal = "Anticancer research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "1",

}

TY - JOUR

T1 - Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

AU - Maehara, Y.

AU - Takahashi, I.

AU - Yoshida, M.

AU - Baba, H.

AU - Kusumoto, H.

AU - Anai, H.

AU - Sugimachi, K.

PY - 1993

Y1 - 1993

N2 - We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

AB - We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

UR - http://www.scopus.com/inward/record.url?scp=0027477514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027477514&partnerID=8YFLogxK

M3 - Article

C2 - 8476223

AN - SCOPUS:0027477514

SN - 0250-7005

VL - 13

SP - 27

EP - 29

JO - Anticancer research

JF - Anticancer research

IS - 1

ER -

Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this